NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Turning Spinal Scars Toward Repair

The study focuses on the molecular mechanisms behind fibrotic scarring after spinal cord injury and identifies the c-Jun–Irf8–CD36 axis as a key pathway that drives scar formation.
While early scar formation stabilizes the wound, excessive fibrosis later creates a dense barrier that blocks axon regrowth and limits functional recovery.
They used single-cell RNA sequencing, spatial transcriptomics, drug intervention, tissue imaging, and behavioral testing in mouse models to map CD36 expression and its regulation.
Salvianolic acid B (a CD36 inhibitor) and T5224 (an AP-1/c-Jun inhibitor) were tested. Both reduced fibrotic scar formation, improved vascular remodeling, supported axonal regrowth, and enhanced motor recovery in mice.
The research team included scientists from the Second Affiliated Hospital of Naval Medical University, Nantong University, and other institutions in China.
The study was published in the journal Burns & Trauma on 12 March 2026.
The findings suggest that targeting the c-Jun–Irf8–CD36 pathway could lead to therapies that tune scar formation—preserving its early protective role while preventing excessive fibrosis—to improve recovery after spinal cord injury.
